Mei Li M. Kwong, M.D.
- Center for Cancer Research
- National Cancer Institute
- CRC/3-5752
- Bethesda, MD 20892
- 240-858-7398
- meili.kwong@nih.gov
RESEARCH SUMMARY
Mei Li M. Kwong, MD is a surgical oncologist and member of Dr. Rosenberg's senior staff. Her research interests focus on adoptive cellular immunotherapies for the treatment of metastatic solid tumors (breast, gastrointestinal, melanoma, ovarian, sarcoma, etc). She has a special interest to increase diversity, inclusion and equity in order to improve access to healthcare and biomedical research for underrepresented groups.
Areas of Expertise
Research
We are harvesting the power of the immune system to treat metastatic cancers. We use tumor-infiltrating lymphocytes and genetically modified T cells to treat patients with metastatic cancers. Most patients have already progressed through multiple types of standardized therapies. Our research focuses on individualized cancer treatments based on tumor mutations. Our bench-to-bedside research continues to seek novel avenues to improve therapy efficiency and duration.
Biography
Mei Li M. Kwong, M.D.
Mei Li M. Kwong, MD is an Assistant Research Physician and surgical oncologist in the Surgery Branch of the National Cancer Institute at the NIH. She was born and raised in La Crosse, Wisconsin and attended Creighton University School of Medicine in Omaha, Nebraska. She began her surgical training at St. Barnabas Medical Center in Livingston, NJ. Her research years focused on tumor immunology under Dr. Steven Rosenberg at the NCI. She completed her general surgery residency at MedStar Georgetown University Hospital-Washington Hospital Center in Washington, DC. This was followed by a Complex General Surgical Oncology fellowship at Loma Linda University in Southern California.